Selventa

Selventa^TM, evolved from Genstruct^®, Inc., analyzes molecular patient data, accelerates the development process and clarifies decisions on therapeutics and diagnostics for pharmaceutical and biotechnology partners. Founded in 2002 and venture funded, Selventa elucidates the mechanistic understanding of complex, molecular data through collaborative projects, licensed software products and the strategic development of well-differentiated pharmaceutical portfolios in a variety of disease areas. Selventa, powered by the Genstruct Technology Platform, uses in-silico Reverse Causal Reasoning approach that translates large-scale data into meaningful, testable molecular mechanisms. As a result, we empower our partners with focused, evidence-based support that helps them make better regulatory, clinical and development decisions.